VolitionRx (VNRX) Competitors

Genfit (NASDAQ:GNFT) and VolitionRx (NYSE:VNRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, community ranking, earnings, analyst recommendations and dividends.

Is GNFT or VNRX more profitable?

Genfit has a net margin of 0.00% compared to VolitionRx's net margin of -2,321.14%.

Company	Net Margins	Return on Equity	Return on Assets
Genfit	N/A	N/A	N/A
VolitionRx	-2,321.14%	N/A	-163.39%

Do analysts recommend GNFT or VNRX?

Genfit currently has a consensus price target of $13.00, suggesting a potential upside of 212.50%. VolitionRx has a consensus price target of $3.33, suggesting a potential upside of 587.29%. Given VolitionRx's higher probable upside, analysts plainly believe VolitionRx is more favorable than Genfit.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genfit	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
VolitionRx	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Do institutionals and insiders hold more shares of GNFT or VNRX?

2.2% of Genfit shares are owned by institutional investors. Comparatively, 8.1% of VolitionRx shares are owned by institutional investors. 4.2% of Genfit shares are owned by insiders. Comparatively, 12.8% of VolitionRx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has better valuation & earnings, GNFT or VNRX?

Genfit has higher revenue and earnings than VolitionRx.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genfit	$76.06M	2.73	-$31.27M	N/A	N/A
VolitionRx	$1.23M	39.62	-$35.32M	-$0.31	-1.56

Does the MarketBeat Community prefer GNFT or VNRX?

Genfit received 55 more outperform votes than VolitionRx when rated by MarketBeat users. Likewise, 69.70% of users gave Genfit an outperform vote while only 20.29% of users gave VolitionRx an outperform vote.

Company	Underperform	Outperform
Genfit	Outperform Votes 69 69.70%	Underperform Votes 30 30.30%
VolitionRx	Outperform Votes 14 20.29%	Underperform Votes 55 79.71%

Which has more risk & volatility, GNFT or VNRX?

Genfit has a beta of 1.22, suggesting that its share price is 22% more volatile than the S&P 500. Comparatively, VolitionRx has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500.

Does the media refer more to GNFT or VNRX?

In the previous week, Genfit had 3 more articles in the media than VolitionRx. MarketBeat recorded 6 mentions for Genfit and 3 mentions for VolitionRx. VolitionRx's average media sentiment score of 0.39 beat Genfit's score of 0.14 indicating that VolitionRx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Genfit	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
VolitionRx	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Genfit beats VolitionRx on 9 of the 15 factors compared between the two stocks.